Amoxicillin + metronidazole + SRP vs Supragingival scaling (plus placebo)
CRP (mg/dL) at end of study · People with periodontitis and metabolic syndrome (no CVD; primary prevention)
1 finding from 1 review
- Periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis 2022 · Cochrane All outcomes12 monthsbeta coefficient -0.002 [-0.19, 0.20]1 studyVery low